Effect on ophthalmic imaging findings of flow-diverting stent treatment covering the origin of the ophthalmic artery.

Choroidal thickness Flow-diverting stent Intracranial aneurysm Ophthalmic artery Optical Coherence Tomography Pipeline embolization device Retinal vascular flow

Journal

Photodiagnosis and photodynamic therapy
ISSN: 1873-1597
Titre abrégé: Photodiagnosis Photodyn Ther
Pays: Netherlands
ID NLM: 101226123

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 16 11 2022
revised: 12 12 2022
accepted: 16 12 2022
medline: 3 4 2023
pubmed: 21 12 2022
entrez: 20 12 2022
Statut: ppublish

Résumé

Flow-diverting stents are devices that are increasingly used in the treatment of intracranial aneurysms and expand the spectrum of endovascular treatment. The patency of side branches and perforators is a major concern about flow-diverting stent (FDS) treatment. From 2011 to 2020, seventy-eight patients in whom the orifice of the ophthalmic artery was covered during FDS treatment were evaluated in this study. Bilateral retinal vascular parameters of study subjects were evaluated with OCT and OCTA. The FDS implanted-side eyes of the patients were defined as the procedure group, and the fellow eyes were considered as the control group. Twenty-seven patients who were treated with FDS covering the ostium of the ophthalmic artery and who could undergo full ophthalmologic examination were included in the study. There was no statistically significant difference found in terms of visual acuity, retinal vascular parameters, and choroidal thickness between the procedure group and the control group (p>0.05). However, in one case, recanalized retinal artery branch occlusion was detected on the side where the FDS was implanted. The orifice of the ophthalmic artery is often covered during FDS treatment for carotid-ophthalmic aneurysms; however, this treatment approach has no significant effect on ophthalmic vascular parameters.

Sections du résumé

BACKGROUND BACKGROUND
Flow-diverting stents are devices that are increasingly used in the treatment of intracranial aneurysms and expand the spectrum of endovascular treatment. The patency of side branches and perforators is a major concern about flow-diverting stent (FDS) treatment.
METHODS METHODS
From 2011 to 2020, seventy-eight patients in whom the orifice of the ophthalmic artery was covered during FDS treatment were evaluated in this study. Bilateral retinal vascular parameters of study subjects were evaluated with OCT and OCTA. The FDS implanted-side eyes of the patients were defined as the procedure group, and the fellow eyes were considered as the control group.
RESULTS RESULTS
Twenty-seven patients who were treated with FDS covering the ostium of the ophthalmic artery and who could undergo full ophthalmologic examination were included in the study. There was no statistically significant difference found in terms of visual acuity, retinal vascular parameters, and choroidal thickness between the procedure group and the control group (p>0.05). However, in one case, recanalized retinal artery branch occlusion was detected on the side where the FDS was implanted.
CONCLUSION CONCLUSIONS
The orifice of the ophthalmic artery is often covered during FDS treatment for carotid-ophthalmic aneurysms; however, this treatment approach has no significant effect on ophthalmic vascular parameters.

Identifiants

pubmed: 36539005
pii: S1572-1000(22)00533-6
doi: 10.1016/j.pdpdt.2022.103247
pii:
doi:

Substances chimiques

Photosensitizing Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103247

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

İzzet Ökçesiz (İ)

Department of Radiology, Erciyes University School of Medicine, Kayseri, Turkiye. Electronic address: izzetokcesiz@erciyes.edu.tr.

Halil Dönmez (H)

Department of Radiology, Erciyes University School of Medicine, Kayseri, Turkiye.

Osman Ahmet Polat (OA)

Department of Ophthalmology, Erciyes University School of Medicine, Kayseri, Turkiye.

Mehmet Alpşahin (M)

Department of Radiology, Erciyes University School of Medicine, Kayseri, Turkiye.

Hatice Kübra Sönmez (HK)

Department of Ophthalmology, Kayseri State Hospital, Kayseri, Turkiye.

Özge Temizyürek (Ö)

Department of Ophthalmology, Erciyes University School of Medicine, Kayseri, Turkiye.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH